HIT Stock Risk & Deep Value Analysis

Health In Tech Inc

Technology โ€ข Software - Application

DVR Score

8.4

out of 10

Hidden Gem

The Bottom Line on HIT

We analyzed Health In Tech Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran HIT through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Apr 18, 2026โ€ขRun Fresh Analysis โ†’โ€ข

Get notified when HIT moves

Same alert types as Telegram โ€” presets or custom thresholds in your ๐Ÿ”” feed.

๐Ÿ“ˆHIT Performance Overview3yr weekly

๐Ÿ“Š

Unlock HIT Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

HIT Quality Rating

8.4
9.0
Growth
8.0
Profitability
8.0
Health
7.0
Capital allocation
7.0
Momentum

HIT Stock Risk Analysis

Overall Risk

Aggressive

Financial Risk

Medium

Market Risk

Medium

About Health In Tech Inc (HIT)

Sector

Technology

Industry

Software - Application

Market Cap Category

small

Market Cap

$82.19M

HIT Deep Value Analysis

Health In Tech (HIT) continues to exhibit strong 10x growth potential, validated by its Q4 and full-year 2025 results, which showed a significant 71% YoY revenue increase to $33.3 million and, critically, achieved full-year net profitability of $1.3 million. This transition from 'unprofitable' status is a material positive development, demonstrating execution on its AI-driven personalized preventive care vision within the expansive digital health market. The recently closed $7.0 million private placement further strengthens its financial runway. While Q4 saw a slight net loss, the overall financial trajectory is positive. Major enterprise contracts and broader clinical validation remain key catalysts for future re-rating, with inherent risks in execution and competition in a highly dynamic sector. The score reflects improved financial fundamentals and continued strategic progress.

HIT Research Sources

Research sources

No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.

For educational context only. Not financial advice.

HIT Red Flags & Warning Signs

  • โš 

    Slower-than-expected client acquisition or contract delays

  • โš 

    Higher-than-anticipated cash burn in Q1/Q2 2026 leading to further dilution

  • โš 

    Increased competitive pressure from larger digital health players

Unlock HIT Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

HIT Financial Health Metrics

Market Cap

$82.19M

P/E Ratio

64.27

Profit Margin

3.84%

Beta (Volatility)

0.15

Earnings Per Share

$0.02

HIT Competitive Moat Analysis

Moat Rating

Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Intangible Assets/IP (proprietary AI algorithms, data analytics)Switching Costs (for employers integrating their platform into benefits)Network Effects (potential with increasing data leading to better outcomes and more users)

The moat is strengthening as HIT accumulates more health data, refines its AI models, and integrates deeper into employer benefit ecosystems, increasing the switching costs for clients. However, new entrants with superior AI or large incumbents could erode this over time.

HIT Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

HIT Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขMajor enterprise contract announcements (Q2-Q4 2026)
  • โ€ขContinued growth in billed enrolled employees (Q2 2026 earnings report)
  • โ€ขProgress on clinical validation studies for platform efficacy (H2 2026)

Medium-Term (6-18 months)

  • โ€ขStrategic partnerships with healthcare providers or insurers (2027)
  • โ€ขExpansion into new geographic markets (2027-2028)
  • โ€ขEnhancements to AI platform functionality and data integration (Ongoing)

Long-Term (18+ months)

  • โ€ขDisruption of traditional employer-sponsored healthcare models (2028+)
  • โ€ขDominant market share in AI-driven personalized preventive care (2029+)
  • โ€ขDeepening of proprietary data moat and predictive analytics capabilities (Ongoing)

Catalysts & Growth Drivers

Sign up free to see growth catalysts

HIT Bull Case: What Could Go Right

  • โœ“

    Acceleration in billed enrolled employee growth rates QoQ

  • โœ“

    Announcement of significant new enterprise clients or partnerships

  • โœ“

    Consistent positive net income and free cash flow generation for subsequent quarters

Bull Case Analysis

Sign up free to see the bull case

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Health In Tech Inc (HIT)?

As of April 18, 2026, Health In Tech Inc has a DVR Score of 8.4 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Health In Tech Inc?

Health In Tech Inc's market capitalization is approximately $82.2M. The company operates in the Technology sector within the Software - Application industry.

What ticker symbol does Health In Tech Inc use?

HIT is the ticker symbol for Health In Tech Inc. The company trades on the NCM.

What is the risk level for HIT stock?

Our analysis rates Health In Tech Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of HIT?

Health In Tech Inc currently has a price-to-earnings (P/E) ratio of 64.3. This is above the market average, suggesting the stock may be priced for high growth expectations.

Is Health In Tech Inc's revenue growing?

Health In Tech Inc has reported revenue growth of 71.0%. The company is showing strong top-line momentum.

Is HIT stock profitable?

Health In Tech Inc has a profit margin of 3.8%. The company is profitable but margins are modest.

How often is the HIT DVR analysis updated?

Our AI-powered analysis of Health In Tech Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 18, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.